Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Global Coalition for Adaptive Research

Global Coalition for Adaptive Research in Collaboration with Cure Brain Cancer Foundation Announce the Opening of Glioblastoma Clinical Trial in Australia
From Global Coalition for Adaptive Research
Via Business Wire
Global Coalition for Adaptive Research Joins The South Pole Trek 4 Cancer to Raise Money for Cancer Research
From Global Coalition for Adaptive Research
Via Business Wire
Global Platform Study Presents Results to Guide Care of Severely Ill Patients With COVID-19 Using Routinely Available Drugs – Simvastatin and Vitamin C
From Global Coalition for Adaptive Research
Via Business Wire
Global Coalition for Adaptive Research and Polaris Group Announce Commencement of ADI-PEG 20 in GBM AGILE Trial
From Global Coalition for Adaptive Research
Via Business Wire
Global Coalition for Adaptive Research and GBM AGILE Partners to Ring The Nasdaq Stock Market Closing Bell in Honor of National Brain Tumor Awareness Month
From Global Coalition for Adaptive Research
Via Business Wire
Global Coalition for Adaptive Research Announces That Regorafenib Has Completed Follow-up in the GBM AGILE Trial for Patients With Glioblastoma
From Global Coalition for Adaptive Research
Via Business Wire
Global Coalition for Adaptive Research, Biohaven, and Vigeo Announce Commencement of Biohaven’s Troriluzole and Vigeo’S VT1021 in GBM AGILE Trial
From Global Coalition for Adaptive Research
Via Business Wire
Tickers BHVN
Global Coalition for Adaptive Research Announces the Discontinued Evaluation of Eritoran in REMAP-COVID
From Global Coalition for Adaptive Research
Via Business Wire
Global Coalition for Adaptive Research Announces Key Updates on GBM AGILE Phase 2-3 Adaptive Platform Trial for Patients With Glioblastoma
From Global Coalition for Adaptive Research
Via Business Wire
Ovarian CanceRx: New Innovative Clinical Research Effort Seeks to Accelerate the Development of New Treatments for Deadliest Gynecological Cancer
From Global Coalition for Adaptive Research
Via Business Wire
Global Coalition for Adaptive Research Announces the Discontinued Evaluation of Apremilast in REMAP-COVID
From Global Coalition for Adaptive Research
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.